Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The stock trades at a forward price-to-earnings (P/E) ratio of 35.4, more than double the healthcare industry average, reflecting high investor ... What is Eli Lilly’s current valuation and required ...

Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...

The success of Eli Lilly & Co. 's weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the ...

We recently published a list of the Best Income Stocks to Invest in Now ... alongside Novo Nordisk. Eli Lilly and Company (NYSE:LLY)’s emphasis on high-demand, high-margin treatments is proving ...

Investors often view Pharmaceutical stocks ... Lilly, and Johnson & Johnson could face more immediate problems from international reference pricing. Each company has products that rank among the ...

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

That said, Eli Lilly could still hit the $1 trillion mark ... Visa has significant growth prospects. Lastly, it is a top income stock, too. Visa has increased its dividends by almost 392% in the past ...